Dr. Derek N. Cunningham , OD
Optometrist • Austin, TX
901 Mopac Expressway South, Building 4 Suite 350
Austin, TX 787465776
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on February 23, 2006; this date does not establish years in practice.
-
Published CMS data list 879 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 92012 — Established patient problem focused exam of visual system: 365 service units.
- 92014 — Established patient complete exam of visual system: 230 service units.
- 92134 — Imaging of retina: 60 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 9 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,348 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Xiidra (Lifitegrast) — 528 prescription fills, including refills.
- Latanoprost — 190 prescription fills, including refills.
- Lotemax Sm (Loteprednol Etabonate) — 137 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 17 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 90% of clinicians listed under Optometrist in Austin, TX (2024, 108 clinicians with data). Median for this group: 111. Middle half: 52 to 227.
More Medicare Part B services than 85% of clinicians listed under Optometrist in Texas (2024, 2,188 clinicians with data). Median for this group: 180. Middle half: 59 to 468.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 816 in 2020 to 879 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
901 Mopac Expressway South
Building 4 Suite 350
Austin, TX 787465776
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Dell Laser Consultants, P.A.. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Waterloo - School Of Optometry
2002
What Public CMS Data Show
Optometrist: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
423 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $134,023 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $97,533 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
2,380 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,119,938 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $197,724.75 across 397 records.
By nature of payment (3 largest of 5)
- Compensation for serving as faculty or as a speaker for a medical education program: $121,500.00 across 32 records.
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $35,462.50 across 14 records.
- Travel and Lodging: $19,265.51 across 162 records.
Reporting-company totals (3 largest of 13)
- Bausch & Lomb Americas Inc.: $79,116.17 across 154 records.
- SUN PHARMACEUTICAL INDUSTRIES INC.: $68,826.42 across 112 records.
- Alcon Vision LLC: $45,131.73 across 87 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
24 years (graduated 2002)
CMS Doctors and Clinicians data list 2002 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Cunningham has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Cunningham as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Austin and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 90% of clinicians listed under Optometrist in Austin, TX (2024, 108 clinicians with data). Median for this group: 111. Middle half: 52 to 227.
More Medicare Part B services than 85% of clinicians listed under Optometrist in Texas (2024, 2,188 clinicians with data). Median for this group: 180. Middle half: 59 to 468.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Optometrist in Austin, TX (2024, 108 clinicians with data). Median for this group: $9,730. Middle half: $4,445 to $21,767.
A higher Medicare-allowed amount than 95% of clinicians listed under Optometrist in Texas (2024, 2,188 clinicians with data). Median for this group: $15,873. Middle half: $5,769 to $39,870.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Optometrist in Austin, TX (2024, 108 clinicians with data). Median for this group: $6,757. Middle half: $3,056 to $14,185.
A higher Medicare payment amount than 95% of clinicians listed under Optometrist in Texas (2024, 2,188 clinicians with data). Median for this group: $10,623. Middle half: $3,766 to $26,834.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Optometrist in Austin, TX (2024, 75 clinicians with data). Median for this group: 29. Middle half: 17 to 80.
More Part D prescriptions than 95% of clinicians listed under Optometrist in Texas (2024, 1,883 clinicians with data). Median for this group: 77. Middle half: 27 to 245.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Optometrist in Austin, TX (2024, 75 clinicians with data). Median for this group: $6,986. Middle half: $222 to $19,380.
A higher Part D drug cost than 95% of clinicians listed under Optometrist in Texas (2024, 1,883 clinicians with data). Median for this group: $6,756. Middle half: $496 to $34,775.
256 active clinicians are listed under Optometrist with a practice address in Austin, TX (5,010 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Austin
0% of these 256 clinicians have the CMS telehealth indicator.
53.9% of these 256 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services stayed about the same: 816 in 2020 and 879 in 2024.
- 2020: 816
- 2021: 817
- 2022: 831
- 2023: 900
- 2024: 879
-
Medicare-allowed amount
Medicare-allowed amount increased 22% from $109,993 in 2020 to $134,023 in 2024.
- 2020: $109,993
- 2021: $129,792
- 2022: $145,120
- 2023: $148,341
- 2024: $134,023
-
Paid by Medicare
Paid by Medicare increased 22% from $79,783 in 2020 to $97,533 in 2024.
- 2020: $79,783
- 2021: $96,497
- 2022: $103,392
- 2023: $109,663
- 2024: $97,533
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 55% from 871 in 2020 to 1,348 in 2024.
- 2020: 871
- 2021: 945
- 2022: 1,067
- 2023: 1,145
- 2024: 1,348
-
30-day fills
30-day fills increased 87% from 1,273 in 2020 to 2,380 in 2024.
- 2020: 1,273
- 2021: 1,449
- 2022: 1,706
- 2023: 1,868
- 2024: 2,380
-
Part D drug cost
Part D drug cost increased 189% from $386,893 in 2020 to $1,119,938 in 2024.
- 2020: $386,893
- 2021: $493,681
- 2022: $623,679
- 2023: $862,957
- 2024: $1,119,938
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 59% from $124,584.13 in 2021 to $197,724.75 in 2025.
- 2021: $124,584.13
- 2022: $140,361.85
- 2023: $145,729.23
- 2024: $122,283.65
- 2025: $197,724.75
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 397 records totaling $197,724.75.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Bausch & Lomb Americas Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
MIEBO | General | $4,800.00 |
| Bausch & Lomb Americas Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
MIEBO | General | $4,800.00 |
| Bausch & Lomb Americas Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
MIEBO | General | $4,800.00 |
| Bausch & Lomb Americas Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
MIEBO | General | $4,800.00 |
| Bausch & Lomb Americas Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
MIEBO | General | $4,800.00 |
| Bausch & Lomb Americas Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
MIEBO | General | $4,800.00 |
| Bausch & Lomb Americas Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
MIEBO | General | $4,800.00 |
| Bausch & Lomb Americas Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
MIEBO | General | $4,800.00 |
| Bausch & Lomb Americas Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
MIEBO | General | $4,800.00 |
| Bausch & Lomb Americas Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
MIEBO | General | $4,800.00 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Consulting Fee
Cash or cash equivalent
|
Cequa | General | $4,800.00 |
| Bausch & Lomb Americas Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
MIEBO | General | $4,800.00 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
Cequa | General | $4,500.00 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
Cequa | General | $4,500.00 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
Cequa | General | $4,500.00 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
Cequa | General | $4,500.00 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
Cequa | General | $4,500.00 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
Cequa | General | $4,500.00 |
| Alcon Vision LLC |
Consulting Fee
Cash or cash equivalent
|
TRYPTYR | General | $4,500.00 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
Cequa | General | $4,500.00 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
Cequa | General | $4,500.00 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
Cequa | General | $4,500.00 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
Cequa | General | $4,500.00 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
Cequa | General | $3,900.00 |
| Alcon Vision LLC |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
TRYPTYR | General | $3,575.00 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
92012
Established patient problem focused exam of visual system
|
365 | 213 | $125.00 | $88.66 |
|
92014
Established patient complete exam of visual system
|
230 | 218 | $150.22 | $126.82 |
|
92134
Imaging of retina
|
60 | 60 | $143.75 | $40.63 |
|
65778
Placement of amniotic membrane on eye surface for wound healing
|
47 | 27 | $1700.00 | $1087.10 |
|
92004
New patient complete exam of visual system
|
42 | 42 | $200.00 | $146.67 |
|
68761
Closure of tear duct opening using plug
|
39 | 36 | $594.87 | $217.86 |
|
92133
Imaging of optic nerve
|
36 | 35 | $134.72 | $35.76 |
|
92083
Exam of visual field with extended testing
|
32 | 30 | $100.00 | $63.99 |
|
92250
Photography of the retina
|
28 | 26 | $100.00 | $34.64 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Xiidra | Lifitegrast | 528 | 34,470 | $733,401.49 | 227 |
| Latanoprost | Latanoprost | 190 | 11,061 | $1,945.46 | 57 |
| Lotemax Sm | Loteprednol Etabonate | 137 | 2,815 | $34,381.98 | 99 |
| Miebo | Perfluorohexyloctane/Pf | 100 | 3,449 | $84,321.81 | 23 |
| Restasis | Cyclosporine | 84 | 5,400 | $106,159.25 | 41 |
| Cequa | Cyclosporine | 60 | 3,075 | $55,783.16 | 23 |
| Vevye | Cyclosporine | 37 | 1,326 | $28,839.70 | 11 |
| Vyzulta | Latanoprostene Bunod | 36 | 1,678 | $15,563.91 | 16 |
| Zylet | Tobramycin/Lotepred Etab | 33 | 801 | $11,512.60 | 32 |
| Prolensa | Bromfenac Sodium | 28 | 913 | $10,215.33 | 22 |
| Eysuvis | Loteprednol Etabonate | 28 | 749 | $13,333.53 | 24 |
| Simbrinza | Brinzolamide/Brimonidine Tart | 22 | 1,048 | $5,629.10 | — |
| Brimonidine Tartrate | Brimonidine Tartrate | 15 | 478 | $2,860.86 | — |
| Combigan | Brimonidine Tartrate/Timolol | 13 | 463 | $3,360.40 | — |
| Alphagan P | Brimonidine Tartrate | 13 | 375 | $2,707.63 | — |
| Tyrvaya | Varenicline Tartrate | 13 | 450 | $9,046.61 | — |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | 307 | $875.26 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 152W00000X
Doctors of optometry (ODs) are the primary health care professionals for the eye. Optometrists examine, diagnose, treat, and manage diseases, injuries, and disorders of the visual system, the eye, and associated structures as well as identify related systemic conditions affecting the eye. An optometrist has completed pre-professional undergraduate education in a college or university and four years of professional education at a college of optometry, leading to the doctor of optometry (O.D.) degree. Some optometrists complete an optional residency in a specific area of practice. Optometrists are eye health care professionals state-licensed to diagnose and treat diseases and disorders of the eye and visual system.
NUCC Taxonomy Code: 152W00000X
Doctors of optometry (ODs) are the primary health care professionals for the eye. Optometrists examine, diagnose, treat, and manage diseases, injuries, and disorders of the visual system, the eye, and associated structures as well as identify related systemic conditions affecting the eye. An optometrist has completed pre-professional undergraduate education in a college or university and four years of professional education at a college of optometry, leading to the doctor of optometry (O.D.) degree. Some optometrists complete an optional residency in a specific area of practice. Optometrists are eye health care professionals state-licensed to diagnose and treat diseases and disorders of the eye and visual system.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPTOMETRY
I20040610000502
TX
9537142666
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Dell Laser Consultants, P.a.
901 S Mopac Expy, Austin, TX 787465889
Phone: 5123470255
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Optometrist
Doctor of Optometry
Optometrist
Optometrist
Doctor of Optometry
Ophthalmology
Doctor of Medicine (M.D.)
Optometrist
Doctor of Optometry
Career & Practice History
NPI enumerated February 23, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Optometrists in Austin
- Dr. Yesha Sharma, OD
- Dr. Dan Mcqueen, OD
- Dr. Jennifer Khanh, OD
- Dr. Selena Aloisio, OD
- Dr. Jeffery Lane, OD
- Dr. Diane Yu-Davis, OD
Mailing Address
901 Mopac Expressway South, Building 4 Suite 350
Austin, TX 787465776
Phone: 5123470255